A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2

Lei, Shu; He, Xiangjun; Yang, Xiao; Gu, Xuan; He, Yijiao; Wang, Jianliu

doi:10.7150/jca.81069

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

open access Global reach, higher impact

Full Text | PDF

J Cancer 2023; 14(4):634-645. doi:10.7150/jca.81069 This issue Cite

Research Paper

A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2

Shu Lei^1,2, Xiangjun He¹, Xiao Yang¹, Xuan Gu¹, Yijiao He¹, Jianliu Wang^1✉

1. Department of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
2. Department of Gynecology and Obstetrics, The Third Affiliated Hospital of Zhengzhou University, No.3 Kangfu Middle Street, Zhengzhou 450052, China.

Citation:

Lei S, He X, Yang X, Gu X, He Y, Wang J. A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2. J Cancer 2023; 14(4):634-645. doi:10.7150/jca.81069. https://www.jcancer.org/v14p0634.htm

Other styles

Abstract

Background: Endometrial carcinoma is one of the most common female malignancies worldwide. Based on our preliminary investigation, DUSP1 was identified as a potential biomarker for endometrial carcinoma prognosis, but its function and mechanism remained unclear.

Methods: In this study, genes highly correlated with DUSP1 in endometrial cancer were found through correlation analysis, and the promoter sequence of DUSP1 was analyzed by PROMO program. Next-generation phosphorylation mass spectrometry was used to explore new downstream target proteins and pathways of DUSP1 in endometrial carcinoma. The mRNA and protein expression levels were detected by real-time quantitative PCR, immunohistochemistry and Western blotting. The cell survival and proliferation were analyzed by CCK8 assay, cell apoptosis was analyzed by Annexin-V-APC and PI dual staining assay, and the cell invasion was analyzed by Transwell method.

Results: (1) There was a high correlation between the expression of DUSP1 and the genes involved in AP-1 complex and its co-expression network. (2) Promoter sequence analysis predicted that the members of AP-1 complex might be the upstream transcriptional regulators of DUSP1. (3) Transfection experiments proved DUSP1 can inhibit tumor growth and invasion, and promote apoptosis by regulating ERK pathway. (4) The results of phosphorylation mass spectrometry showed that overexpression of DUSP1 mainly dephosphorylated EPHA2 in endometrial carcinoma, and co-immunoprecipitation verified the protein interaction between DUSP1 and EPHA2. (5) Overexpression or knockdown of EPHA2 significantly changed the phosphorylation level of EPHA2. (6) The expression of EPHA2 protein was high in patients with more aggressive endometrial cancer. (7) Using EPHA2 inhibitor could significantly slow down the growth rate of tumor cells.

Conclusion: (1) There exists a mutual regulation relationship between DUSP1 and AP-1 co-expression network in endometrial carcinoma. (2) It is reported for the first time that DUSP1 phosphatase acts on the ser899 site of EphA2 in endometrial carcinoma. (3) DUSP1 can inhibit tumor growth and invasion, and promote apoptosis by regulating MAPK pathway through directly dephosphorylating ERK, or by dephosphorylating EPHA2.

Keywords: Endometrial carcinoma, DUSP1, AP-1 complex, MAPK pathway, EPHA2.

Citation styles

APA

Lei, S., He, X., Yang, X., Gu, X., He, Y., Wang, J. (2023). A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2. Journal of Cancer, 14(4), 634-645. https://doi.org/10.7150/jca.81069.

ACS

Lei, S.; He, X.; Yang, X.; Gu, X.; He, Y.; Wang, J. A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2. J. Cancer 2023, 14 (4), 634-645. DOI: 10.7150/jca.81069.

NLM

CSE

Lei S, He X, Yang X, Gu X, He Y, Wang J. 2023. A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2. J Cancer. 14(4):634-645.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.